In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 91 for your search:
Cancer Type/Condition:  rectal cancer, colon cancer
Trial Type:  Screening, Prevention
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Screening
Status: Active
Age: 58 to 60
Sponsor: Other
Protocol IDs: 14334-c27.2, NCT01739608

2.

Phase: Phase IV
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1, NCT02032914

3.

Phase: Phase IV
Type: Diagnostic, Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 6011440, DMED-1658-13, NCT02065037

4.

Phase: Phase III, Phase II
Type: Screening
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 190-CLD-AOS, NCT00867724

5.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: S10251, NCT01426490

6.

Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: SQ2011SF12RJ, SQ2011SF12-20121010, NCT02066688

7.

Phase: Phase III
Type: Screening
Status: Active
Age: 55 to 64
Sponsor: Other
Protocol IDs: NordICC, NCT00883792

8.

Phase: Phase III
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000654114, FFCD-PRODIGE-13, 2009-A00536-51, EU-20979, PRODIGE 13, FFCD 0902, NCT00995202

9.

Phase: Phase III
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0820, U10CA037429, NCI-2012-02067, NCT01349881

10.

Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRE-2011.125-T, NCT01434199

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPP-FAP-310, NCT01483144

12.

Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 5130003, LLUMCGI2013, NCT01782014

13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 69
Sponsor: Other
Protocol IDs: D-13-01, 2013-004269-15, NCT02125409

14.

Phase: Phase II, Phase I
Type: Diagnostic, Screening, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSP-IL-LIT-0703_S_01, NCT00715325

15.

Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 40 to 80
Sponsor: NIDDK
Protocol IDs: 080173, 08-DK-0173, NCT00719641

16.

Phase: Phase II
Type: Prevention
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: 23266, KUN 2003-2911, NCT00319007

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: MIRACLE, NCT01360320

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 40 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: NER1006-01/2012 (OPT), NCT01714466

21.

Phase: Phase II
Type: Screening
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CD-1158, NCT01549535

22.

Phase: Phase II
Type: Screening
Status: Active
Age: 50 to 74
Sponsor: NCI, Other
Protocol IDs: UH3CA188640, 1UH2AT007782-01, NCT01742065

23.

Phase: Phase II
Type: Screening
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: WCTU065, NCT01972451

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MES-CT 01, NCT02077777

25.

Phase: Phase I
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: 633, NCT00124163
1     
New Search